Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-08 2:48 pm Purchase | 2023-02-08 | 13G | ARCA biopharma, Inc. ABIO | BML Investment Partners, L.P. | 71,521 5.950% | 8,033 (+12.65%) | Filing History |
| 2022-07-08 4:30 pm Purchase | 2022-07-01 | 13D | ARCA biopharma, Inc. ABIO | Funicular Funds LP | 215,093 17.910% | 215,093 (New Position) | Filing History |
| 2022-06-21 4:30 pm Purchase | 2022-06-15 | 13D | ARCA biopharma, Inc. ABIO | Funicular Fund LP | 215,093 17.910% | 15,320 (+7.67%) | Filing History |
| 2022-05-27 4:40 pm Purchase | 2022-05-25 | 13D | ARCA biopharma, Inc. ABIO | Ma-Weaver Jacob | 215,038 17.910% | 215,038 (New Position) | Filing History |
| 2022-05-11 4:56 pm Purchase | 2022-05-09 | 13D | ARCA biopharma, Inc. ABIO | Funicular Fund LP | 199,773 16.640% | 18,848 (+10.42%) | Filing History |
| 2022-04-14 4:38 pm Purchase | 2022-04-12 | 13D | ARCA biopharma, Inc. ABIO | Funicular Fund LP | 180,925 15.060% | 18,842 (+11.63%) | Filing History |
| 2022-04-04 5:10 pm Purchase | 2022-03-31 | 13D | ARCA biopharma, Inc. ABIO | Funicular Fund LP | 162,083 13.500% | 84,163 (+108.01%) | Filing History |
| 2022-03-28 4:20 pm Purchase | 2022-03-18 | 13D | ARCA biopharma, Inc. ABIO | Funicular Fund LP | 77,920 6.490% | 77,920 (New Position) | Filing History |
| 2022-01-27 3:53 pm Purchase | 2022-01-24 | 13G | ARCA biopharma, Inc. ABIO | BML Investment Partners, L.P. | 63,488 5.300% | 63,488 (New Position) | Filing History |
| 2021-02-10 1:45 pm Purchase | 2020-12-31 | 13G | ARCA biopharma, Inc. ABIO | Renaissance Technologies LLC | 17,125 2.200% | 5,244 (+44.14%) | Filing History |
| 2021-02-10 10:30 am Sale | 2020-12-31 | 13G | ARCA biopharma, Inc. ABIO | Altium Capital Management LLC | 0 0.000% | -14,500 (Position Closed) | Filing History |
| 2021-01-06 12:31 pm Sale | 2020-12-31 | 13G | ARCA biopharma, Inc. ABIO | SABBY MANAGEMENT LLC | 0 0.000% | -16,168 (Position Closed) | Filing History |
| 2020-06-10 3:06 pm Purchase | 2020-06-01 | 13G | ARCA biopharma, Inc. ABIO | Altium Capital Management LLC | 14,500 9.990% | 14,500 (New Position) | Filing History |
| 2020-06-01 2:07 pm Purchase | 2020-06-01 | 13G | ARCA biopharma, Inc. ABIO | SABBY MANAGEMENT LLC | 16,168 11.000% | 16,168 (New Position) | Filing History |